Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to learn about the short-term effects of aerobic exercise in heart failure patients who were given exercise prescription with cardiopulmonary exercise stres test acocording to aerobic capacity . The main question it aims to answer is:
Does aerobic exercise increase aerobic capacity and quality of life Participants already taking aerobic capacity as part of their regular medical care for Heart failure will asses with cardiopulmonary exercise test and clinical questionaries about quality of life and depression-anxiety level before and after aerobic exercise treatment .
The goal of this observational study is to learn about the short-term effects of aerobic exercise in heart failure patients who were given exercise prescription with cardiopulmonary exercise stres test acocording to aerobic capacity . The main question it aims to answer is:
Does aerobic exercise increase aerobic capacity and quality of life Participants already taking aerobic capacity as part of their regular medical care for Heart failure will asses with cardiopulmonary exercise test and clinical questionaries about quality of life and depression-anxiety level before and after aerobic exercise treatment .
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| aerobic exercise |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aerobic exercise | Other | continuous, moderate intencity aerobic exercise, 3 days a week, 30 minutes per day, 150/min per week for a total of 6 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| cardiopulmonary exercise test results | Cardiovascular responses: VO2 max value (ml/kg/dk) | 6 weeks |
| cardiopulmonary exercise test results | Cardiovascular responses: heart rate (bpm, beats/min) | 6 weeks |
| cardiopulmonary exercise test results | gas exchange response: VE/VCO2: EQCO2: Ventilatory equivalent for carbon dioxide minute ventilation while the produced COâ‚‚ is removed, | 6 weeks |
| cardiovascular exercise test result: Gas exchange parameters: | PETCOâ‚‚ (partial end-tidal carbon dioxide), kilopascal | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Short Form (36) Health Scale | Short Form (36) Health Scale Description: The SF-36 is a widely used, patient-reported survey of health status designed to assess overall health-related quality of life. It evaluates physical and mental health across multiple dimensions and is commonly used in clinical research and health outcomes studies. Domains Assessed (8 Subscales): Physical Functioning , Role Limitations due to Physical Health,Pain, General Health Perceptions Vitality, Social Functioning, Role Limitations due to Emotional Problems, Mental Health These can also be summarized into two main component scores: Physical Component Summary (PCS) Mental Component Summary (MCS) Scoring Range: Each subscale is scored from 0 to 100. 0 represents the worst possible health status; 100 represents the best possible health status. Interpretation of Scores: Higher scores indicate better health outcomes and higher quality of life, lower scores reflect poorer perceived healt |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
18-75 age of years , male and female , diagnosed with heart failure with reduced EF
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ankara City Hospital | Ankara | Çankaya | 06800 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33021355 | Background | Lelonek M. Heart failure with preserved ejection fraction after the PARAGON-HF trial results: current knowledge and future directions. Kardiol Pol. 2020 Dec 23;78(12):1199-1205. doi: 10.33963/KP.15639. Epub 2020 Oct 6. | |
| 29174292 | Background | Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, Allison M, Hemingway H, Cleland JG, McMurray JJV, Rahimi K. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018 Feb 10;391(10120):572-580. doi: 10.1016/S0140-6736(17)32520-5. Epub 2017 Nov 21. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 weeks |
| Hospital Anxiety and Depression Scale | The Hospital Anxiety and Depression Scale (HADS) is a self-assessment tool developed to detect states of anxiety and depression in patients in non-psychiatric hospital clinics. It is widely used in both clinical practice and research settings to screen for emotional distress, especially in individuals with physical illnesses. Structure: The scale consists of 14 items, divided into two subscales: HADS-A (Anxiety) - 7 items HADS-D (Depression) - 7 items Each item assesses symptoms experienced over the past week. Scoring Range: Each item is scored from 0 to 3. Subscale scores range from 0 to 21 for both anxiety and depression. Interpretation of Scores (per subscale): 0-7: Normal 8-10: Borderline abnormal (mild) 11-21: Abnormal (clinically significant) Direction of Scores: Higher scores indicate greater severity of anxiety or depression symptoms. Lower scores suggest fewer or no symptoms. | 6 weeks |